US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.185
  • +0.025+0.19%
Trading Apr 19 14:18 ET
41.73BMarket Cap36.52P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49095
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.co.jp

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.A., Inc.
  • 1.72B
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Costa Saroukos
  • Director and Chief Financial Officer
  • 2.49B
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Koki Sato
  • Corporate Strategy Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Teresa Bitetti
  • President, Global Oncology Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Milano Furuta
  • President, Japan Pharma Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 972.00M
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Yoshiaki Fujimori
  • Independent Director
  • 41.00M
  • Kimberly A. Reed
  • Independent Director
  • 34.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Michel Orsinger
  • Independent Director
  • 39.00M
  • Ian T. Clark
  • Independent Director
  • 38.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 38.00M
  • Emiko Higashi
  • Independent Director
  • 43.00M
  • Olivier Bohuon
  • Independent Director
  • 38.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 32.00M
  • Miki Tsusaka
  • Independent Director
  • --
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg